Quanterix, Gothenberg Researchers Show Potential Link Between Heart Attacks and Alzheimer's Marker | GenomeWeb

By Adam Bonislawski

Scientists from Quanterix and the University of Gothenberg have discovered evidence of a relationship between hypoxia and increased expression of the amyloid-beta1-42 peptide.

The work, which was presented this week at the American Academy of Neurology annual meeting, reinforces a hypothesis held by Alzheimer's researchers that the disease could be linked to cardiovascular conditions like atherosclerosis or cardiac arrest that cause a reduction in the supply of oxygen to the brain.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.